Karam Pal Singh

Karam Pal Singh


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in Cells
Verified
Journal Article
Open access
PDF file
RKRekha Khandia
Rekha Khandia
Maryam DadarMaryam Dadar
Maryam Dadar
AMAshok Munjal
Ashok Munjal
Kuldeep DhamaKuldeep Dhama
Kuldeep Dhama
Kumaragurubaran KarthikKumaragurubaran Karthik
Kumaragurubaran Karthik
WCWanpen Chaicumpa
Wanpen Chaicumpa
Autophagy (self-eating) is a conserved cellular degradation process that plays important roles in maintaining homeostasis and preventing nutritional, metabolic, and infection-mediated stresses. Autophagy dysfunction can have various pathological consequences, including tumor progression, pathogen hyper-virulence, and neurodegeneration. This review describes the mechanisms of autophagy and its associations with other cell death mechanisms, including apoptosis, necrosis, necroptosis, and autosis. Autophagy has both positive and negative roles in infection, cancer, neural development, metabolism, cardiovascular health, immunity, and iron homeostasis. Genetic defects in autophagy can have pathological consequences, such as static childhood encephalopathy with neurodegeneration in adulthood, Crohn’s disease, hereditary spastic paraparesis, Danon disease, X-linked myopathy with excessive autophagy, and sporadic inclusion body myositis. Further studies on the process of autophagy in different microbial infections could help to design and develop novel therapeutic strategies against important pathogenic microbes. This review on the progress and prospects of autophagy research describes various activators and suppressors, which could be used to design novel intervention strategies against numerous diseases and develop therapeutic drugs to protect human and animal health.

4 September 2019 in Vaccines
Verified
Journal Article
Open access
PDF file
SSSWATI SACHAN
SWATI SACHAN
Kuldeep DhamaKuldeep Dhama
Kuldeep Dhama
SLShyma K. Latheef
Shyma K. Latheef
HSHari Abdul Samad
Hari Abdul Samad
Asok kumarAsok kumar
Asok kumar
RSRaj Kumar Singh
Raj Kumar Singh
Infectious bursal disease (IBD), caused by infectious bursal disease virus (IBDV), is characterized by severe immunosuppression in young chicks of 3 to 6 week age group. Although vaccines are available to prevent IBD, outbreaks of disease are still noticed in the field among vaccinated flocks. Further, the birds surviving IBD become susceptible to secondary infections caused by various viral and bacterial agents. This study assessed the immunoprophylactic potential of Cytosine-guanosinedeoxynucleotide (CpG) oligodeoxynucleotides (ODN) and Tinospora cordifolia stem aqueous extract in the specific pathogen free (SPF) chicks, experimentally infected with very virulent IBDV (vvIBDV). Both of these agents (CpG ODN and herbal extract) showed significant increase in the IFN-γ, IL-2, IL-4, and IL-1 levels in the peripheral blood mononuclear cells (PBMCs) (p < 0.05) of chickens in the treatment groups following IBD infection. Further we found significant reduction in mortality rate in vvIBDV infected chicks treated with either, or in combination, compared with the birds of control group. Additionally, the adjuvant or immune enhancing potential of these two immunomodulatory agents with the commercially available IBDV vaccine was determined in chicks. The augmentation of vaccine response in terms of an enhanced antibody titer after vaccination, along with either or a combination of the two agents was noticed. The findings provide a way forward to counter the menace of IBDV in the poultry sector through use of these herbal or synthetic immunomodulatory supplements.

3 March 2010 in Veterinary Microbiology
Verified
Journal Article
Closed access
CUChannakeshava Sokke Umeshappa
Channakeshava Sokke Umeshappa
KSKaram Pal Singh
Karam Pal Singh
RNRoopa Hebbandi Nanjundappa
Roopa Hebbandi Nanjundappa
APAwadh Bihari Pandey
Awadh Bihari Pandey

7 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSM. Saminathan
M. Saminathan
KSKaram Pal Singh
Karam Pal Singh
SVS. Vineetha
S. Vineetha
MMMadhulina Maity
Madhulina Maity
SBS. K. Biswas
S. K. Biswas
PMP. P. C. Mertens
P. P. C. Mertens
Transplacental transmission (TPT) of wild-type Indian BTV-1 had never been experimentally proved. This study was first time investigated TPT of Indian BTV-1 (isolated from aborted and stillborn goat fetal spleens). The sequential pathology, virological and immune cell kinetics (CD4+, CD8+T-lymphocytes and NK cells in spleen and PBMCs), and apoptosis in IFNAR1-blocked pregnant mice during early (infected on 1 GD) and mid (infected on 8 GD) gestation have been studied. There was higher rate of TPT during mid stage (71.43%) than early (57.14%) stage. In early stage reduced implantation sites, early embryonic deaths, abortions, and necro-haemorrhagic lesions had observed. Mid stage, congenital defects and neurological lesions in foetuses like haemorrhages, diffuse cerebral edema, necrotizing encephalitis and decreased bone size (Alizarin red staining) were noticed. BTV-1 antigen was first time demonstrable in cells of mesometrium, decidua of embryos, placenta, uterus, ovary, and brain of foetuses by immunohistochemistry and quantified by real-time qRT-PCR. BTV-inoculated mice were seroconverted by 7 and 5 dpi, and reached peak levels by 15 and 9 dpi in early and mid gestation, respectively. CD4+and CD8+cells were significantly decreased (increased ratio) on 7 dpi but subsequently increased on 15 dpi in early gestation. In mid gestation, increased CD8+cells (decreased ratio) were observed. Apoptotic cells in PBMCs and tissues increased during peak viral load. This first time TPT of wild-type Indian BTV-1 deserves to be reported for implementation of control strategies. This model will be very suitable for further research into mechanisms of TPT, overwintering, and vaccination strategies.

1 September 2016 in VirusDisease
Verified
Journal Article
Closed access
PDF file
BMB. P. Madhu
B. P. Madhu
KSKaram Pal Singh
Karam Pal Singh
MSM. Saminathan
M. Saminathan
RSR. Singh
R. Singh
NSN. Shivasharanappa
N. Shivasharanappa
VMV. Manjunatha
V. Manjunatha

21 December 2015 in Virus Genes
Verified
Journal Article
Closed access
PDF file
BMB. P. Madhu
B. P. Madhu
KSKaram Pal Singh
Karam Pal Singh
MSM. Saminathan
M. Saminathan
RSR. Singh
R. Singh
ATA. K. Tiwari
A. K. Tiwari
GMG. B. Manjunathareddy
G. B. Manjunathareddy